Successfully treated pneumatosis cystoides intestinalis with pneumoperitoneum onset in a patient administered α-glucosidase inhibitor

Acta Med Okayama. 2013;67(2):123-8. doi: 10.18926/AMO/49672.

Abstract

An 80-year-old woman, who had been administered α-glucosidase inhibitor for diabetes, was brought to the hospital with the sensation of abdominal fullness and pain. Abdominal computed tomography indicated pneumatosis cystoides intestinalis (PCI) in the small intestinal wall, with free air within the abdomen. A blood examination showed no increases in white blood cells or C-reactive protein level. The patient's condition improved with conservative therapy. PCI with pneumoperitoneum induced by α-glucosidase inhibitor is rare, with only 27 cases (excluding the present case) reported in Japan to date. In PCI with pneumoperitoneum, differentiation from gastrointestinal perforation is important and following the clinical symptoms over time is vital.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Aged, 80 and over
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glycoside Hydrolase Inhibitors*
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Pneumatosis Cystoides Intestinalis / chemically induced*
  • Pneumatosis Cystoides Intestinalis / therapy
  • Pneumoperitoneum / chemically induced*
  • Pneumoperitoneum / therapy

Substances

  • Glycoside Hydrolase Inhibitors
  • Hypoglycemic Agents